Indaptus Therapeutics, Inc. (INDP)
1.15
+0.02
(+1.77%)
USD |
NASDAQ |
Sep 02, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Indaptus Therapeutics Enterprise Value : 139.01M for Sept. 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 01, 2026 | 139.01M |
| August 31, 2026 | 141.01M |
| August 28, 2026 | 140.34M |
| August 27, 2026 | 143.01M |
| August 26, 2026 | 140.34M |
| August 25, 2026 | 134.35M |
| August 24, 2026 | 143.01M |
| August 21, 2026 | 160.33M |
| August 20, 2026 | 172.32M |
| August 19, 2026 | 113.69M |
| August 18, 2026 | 113.17M |
| August 17, 2026 | 121.69M |
| August 14, 2026 | 131.02M |
| August 13, 2026 | 129.68M |
| August 12, 2026 | 124.35M |
| August 11, 2026 | 147.00M |
| August 10, 2026 | 147.00M |
| August 07, 2026 | 145.67M |
| August 06, 2026 | 155.00M |
| August 05, 2026 | 165.66M |
| August 04, 2026 | 169.66M |
| August 03, 2026 | 162.99M |
| July 31, 2026 | 160.33M |
| July 30, 2026 | 180.32M |
| July 29, 2026 | 230.95M |
| Date | Value |
|---|---|
| July 28, 2026 | 218.96M |
| July 27, 2026 | 260.26M |
| July 24, 2026 | 336.21M |
| July 23, 2026 | 357.53M |
| July 22, 2026 | 340.87M |
| July 21, 2026 | 324.22M |
| July 20, 2026 | 316.22M |
| July 17, 2026 | 325.55M |
| July 16, 2026 | 325.55M |
| July 15, 2026 | 364.19M |
| July 14, 2026 | 338.87M |
| July 13, 2026 | 338.87M |
| July 10, 2026 | 338.87M |
| July 09, 2026 | 321.55M |
| July 08, 2026 | 314.89M |
| July 07, 2026 | 344.20M |
| July 06, 2026 | 368.19M |
| July 02, 2026 | 392.17M |
| July 01, 2026 | 380.18M |
| June 30, 2026 | 388.17M |
| June 29, 2026 | 345.02M |
| June 26, 2026 | 384.66M |
| June 25, 2026 | 367.67M |
| June 24, 2026 | 400.51M |
| June 23, 2026 | 418.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cypherpunk Technologies, Inc. | 176.69M |
| ACADIA Pharmaceuticals, Inc. | 4.090B |
| Alnylam Pharmaceuticals, Inc. | 32.59B |
| Anika Therapeutics, Inc. | 269.35M |
| Savara, Inc. | 956.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.795M |
| Total Expenses (Quarterly) | 1.795M |
| EPS Diluted (Quarterly) | -0.0155 |
| Earnings Yield | -606.5% |
| Normalized Earnings Yield | -581.86 |